Alignment Healthcare (ALHC) Q4 2024: Membership Surges 59% Fueling First Full-Year Adjusted EBITDA Profitability
Alignment Healthcare’s accelerated membership growth and robust medical management delivered a milestone year of profitability and margin expansion, positioning the company for sustained multi-year growth driven by STARS rating tailwinds and cohort maturation dynamics.
Summary
- Distinctive Care-First Model: Alignment’s clinical engagement approach underpins superior cost control and quality outcomes in Medicare Advantage.
- Operational Scale and Efficiency: Strong membership growth outpaced expense increases, driving adjusted EBITDA profitability and margin expansion.
- Multi-Year Growth Visibility: Star rating enhancements and cohort dynamics create embedded profitability growth beyond membership increases.
Business Overview
Alignment Healthcare operates a Medicare Advantage (MA) health plan business focused on delivering coordinated, high-quality care to seniors. Revenue is primarily generated from premiums paid by the Centers for Medicare & Medicaid Services (CMS) for enrolled members. The company’s model emphasizes care management through its proprietary AVA technology platform and a large clinical workforce, enabling improved health outcomes and cost efficiencies. Its major segments include California and expanding ex-California markets, with an increasing footprint outside its original home state.
Performance Analysis
In Q4 2024, Alignment Healthcare’s membership reached approximately 189,100, up 58.6% year-over-year, significantly exceeding initial guidance by over 25,000 members. This robust growth fueled total revenue of $701.2 million, a 50.7% increase year-over-year. Excluding the ACO REACH program, revenue growth was even stronger at 61.4%. Adjusted gross profit improved markedly to $87.9 million, supported by a medical benefits ratio (MBR) of 87.5%, reflecting a 200 basis point improvement compared to the prior year. The company achieved adjusted EBITDA profitability of $1.4 million in the quarter, marking a 400 basis point margin expansion year-over-year.
For the full year, revenue grew 48.3% to $2.7 billion, driven by membership growth and improved medical management. Adjusted gross profit reached $302.6 million with an MBR of 88.8%, representing a 200 basis point improvement versus 2023. The company reported positive adjusted EBITDA of $1.3 million for the year, its first full-year profitability as a public company. These results underscore Alignment’s ability to scale operations efficiently while maintaining disciplined cost control despite rapid growth.
- Membership Growth Outperformance: Surpassing guidance by 21%, reflecting strong market demand and effective sales execution.
- Medical Benefits Ratio Improvement: MBR declines driven by lower inpatient admissions per thousand and effective clinical engagement.
- Operating Expense Leverage: SG&A increased only 23% year-over-year versus 59% membership growth, reducing adjusted SG&A as a percentage of revenue by 330 basis points.
Overall, Alignment demonstrated strong operational discipline, leveraging its care management capabilities and technology to improve quality and control costs, which translated into meaningful margin expansion and profitability despite aggressive growth.
Executive Commentary
"By using our clinical resources and technology to improve outcomes and manage medical expenses, we grew while others pulled back. With strong momentum from the annual enrollment period and industry-leading stars performance, we enter 2025 positioned for success and confident that we are fulfilling our vision for Medicare Advantage done right."
John Kao, Founder and CEO
"We achieved our break-even profitability goal with full-year adjusted EBITDA of positive 1 million and did so while onboarding more net new members in 2024 than in the prior four years combined. This demonstrates the differentiated power of our model to scale outcomes and places us on track to drive continued adjusted EBITDA margin expansion in 2025."
Thomas Freeman, Chief Financial Officer
Strategic Positioning
1. Care-First Model Drives Differentiated Performance
Alignment approaches Medicare Advantage as a care management business rather than a traditional actuarial underwriting operation. Employing over 400 clinical staff who leverage AVA, its proprietary technology platform, the company delivers personalized, home- and virtual-based care. This model enables superior control over medical quality and costs, resulting in lower inpatient admissions and improved MBRs compared to peers.
2. STARS Ratings as a Competitive Moat
The company’s industry-leading STARS ratings underpin higher CMS reimbursements and member retention. With 95% of California members in four-star or above plans for 2025 payment year—27% higher than competitors—and nearly 98% nationally, Alignment is well positioned for payment year 2026 and beyond. Upcoming CMS changes, including the health equity index, are expected to further strengthen Alignment’s STARS advantage, enhancing growth and margin potential.
3. Cohort Maturation Embedded Profitability
Over 50% of members are in their first or second year, where adjusted gross profit per member per month (PMPM) is lower. As cohorts mature, gross profit increases substantially—from $90 PMPM in year one to $230 PMPM in year five and beyond—embedding nearly $600 million of gross profit opportunity within the existing membership base. This dynamic offers a pathway to double gross profit without additional membership growth.
4. Geographic Expansion with Replicable Model
Ex-California markets grew over 100% year-over-year in Q4, with Nevada surpassing 10,000 members. The company is successfully replicating its care model across markets, maintaining strong clinical engagement and cost control. Ex-California inpatient admissions per thousand are lower than the consolidated average, indicating operational consistency and scalability.
5. Financial Strength and Capital Efficiency
Alignment ended 2024 with $471 million in cash and investments, following convertible notes issuance and term loan repayment, reducing interest expense by approximately $10 million annually. Operating leverage improved with adjusted SG&A growth well below membership growth, and capex is expected to remain moderate, supporting organic growth without external financing needs.
Key Considerations
Alignment’s 2024 results and 2025 guidance reflect a strategic balance of growth and profitability, anchored by a differentiated care management approach and strong STARS performance.
- Membership Momentum: Continued strong growth in both California and ex-California markets, with ex-California growing faster percentage-wise but California expected to contribute over half of net growth.
- MBR Dynamics: 2025 guidance assumes modest MBR improvement driven by cohort maturation and benefit design changes, offset by risk adjustment model phase-in and Part D Inflation Reduction Act impacts.
- Part D Seasonality Shift: Anticipated flatter MBR slope in Part D claims throughout 2025, lowering first-half MBR and increasing second-half MBR compared to prior years.
- Retention Stability: Retention rates during the Annual Enrollment Period remained consistent with prior year despite benefit design adjustments aimed at margin durability.
- Operational Leverage: SG&A expense growth is well controlled relative to membership, supporting margin expansion.
Risks
Key risks include regulatory changes affecting Medicare Advantage reimbursement, potential shifts in CMS star rating methodologies, utilization variability, and the ability to sustain clinical engagement at scale. The company’s reliance on cohort maturation for embedded profitability also introduces timing risk. Additionally, competitive pressures and market dynamics could impact membership growth and retention.
Forward Outlook
For Q1 2025, Alignment projects:
- Health plan membership between 211,000 and 215,000 members
- Revenue ranging from $880 million to $895 million
- Adjusted gross profit between $89 million and $97 million
- Adjusted EBITDA between $2 million and $10 million
For full-year 2025, management expects:
- Health plan membership of 227,000 to 233,000 members, raising the midpoint by 2,000 from prior guidance
- Revenue of $3.72 billion to $3.78 billion, representing 37.6% to 39.6% year-over-year growth
- Adjusted gross profit between $415 million and $445 million, implying an MBR of approximately 88.5%
- Adjusted EBITDA of $35 million to $60 million, projecting 130 basis points of margin expansion
Management highlighted the positive impact of cohort maturation, STARS rating tailwinds, and operational efficiency gains as key drivers supporting this outlook.
Takeaways
Alignment Healthcare’s Q4 and full-year 2024 results confirm the viability of a care-focused Medicare Advantage model that simultaneously drives growth, quality, and profitability.
- Model Differentiation: The company’s emphasis on clinical engagement and technology integration materially reduces inpatient admissions and improves MBR, setting it apart in a challenging MA environment.
- Scalable Growth: Rapid membership expansion, especially outside California, demonstrates successful replication of the care model and positions the company for sustained multi-year growth.
- Embedded Profitability Upside: Cohort maturation provides a significant embedded gross profit runway, reducing reliance on continuous membership growth for margin expansion.
Conclusion
Alignment Healthcare’s strong operational execution and strategic focus on care management have propelled it to its first full-year adjusted EBITDA profitability as a public company. With robust membership growth, improving cost metrics, and favorable regulatory tailwinds, the company is positioned to accelerate margin expansion and sustain growth through 2025 and beyond.
Industry Read-Through
Alignment’s results illustrate a broader industry trend where Medicare Advantage plans that prioritize clinical engagement and quality metrics can outperform peers facing margin pressures. The company’s ability to grow membership while improving MBR contrasts with peers experiencing rising costs and stagnant or shrinking enrollment. Additionally, the evolving CMS STARS program and risk adjustment model changes create opportunities for plans with strong quality management to secure higher reimbursements and competitive advantage. Investors and operators in the MA space should monitor cohort maturation impacts and Part D program adjustments as critical factors shaping future profitability.